Bethesda, MD
Description
The National Heart, Lung, and Blood Institute (NHLBI), Division of Blood Disorders and Resources (DBDR) and the National Cancer Institute (NCI), Center for Strategic Scientific Initiatives (CSSI) convened a Working Group meeting on August 25 and 26, 2014, in Bethesda, MD, to bring together research scientists and clinicians to evaluate recent and emerging data regarding cancer-associated thrombosis, novel approaches to thrombotic risk assessment, and the results of clinical trials on anti-thrombotic treatment of cancer patients. The meeting goals integrated the DBDR mission to enhance health by promoting the prevention and treatment of thrombosis with the CSSI mission to employ trans-disciplinary approaches to enable progress in cancer research.